Variant report

Variant	nsv892639
Chromosome Location	chr9:16190403-16242088
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:16192253-16192453	HepG2	liver:	n/a	n/a
2	ATF3	chr9:16192046-16192582	A549	lung:	n/a	n/a
3	BCL3	chr9:16191990-16192528	A549	lung:	n/a	n/a
4	BCL3	chr9:16203147-16203808	A549	lung:	n/a	n/a
5	BHLHE40	chr9:16207261-16207327	GM12878	blood:	n/a	n/a
6	BHLHE40	chr9:16221777-16222097	GM12878	blood:	n/a	n/a
7	BHLHE40	chr9:16192197-16192465	GM12878	blood:	n/a	n/a
8	BRCA1	chr9:16203538-16203576	Hela-S3	cervix:	n/a	n/a
9	BRCA1	chr9:16192048-16192439	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr9:16203461-16203756	IMR90	lung:	n/a	n/a
11	CEBPB	chr9:16236289-16236673	A549	lung:	n/a	n/a
12	CEBPB	chr9:16192723-16192944	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr9:16192166-16192504	MCF-7	breast:	n/a	n/a
14	CEBPB	chr9:16192151-16192493	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr9:16203146-16203901	A549	lung:	n/a	n/a
16	CEBPB	chr9:16236214-16236699	IMR90	lung:	n/a	n/a
17	CEBPB	chr9:16236327-16236675	A549	lung:	n/a	n/a
18	CEBPB	chr9:16236346-16236654	HepG2	liver:	n/a	n/a
19	CEBPB	chr9:16192156-16192489	A549	lung:	n/a	n/a
20	CEBPB	chr9:16192695-16192956	A549	lung:	n/a	n/a
21	CEBPB	chr9:16236307-16236698	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr9:16191728-16192481	IMR90	lung:	n/a	n/a
23	CEBPB	chr9:16203222-16203773	A549	lung:	n/a	n/a
24	CEBPB	chr9:16236229-16236824	A549	lung:	n/a	n/a
25	CEBPB	chr9:16203406-16203759	Hela-S3	cervix:	n/a	n/a
26	CHD2	chr9:16203363-16203700	Hela-S3	cervix:	n/a	n/a
27	CHD2	chr9:16192279-16192466	Hela-S3	cervix:	n/a	n/a
28	CHD2	chr9:16192181-16192450	GM12878	blood:	n/a	n/a
29	CHD2	chr9:16233684-16233721	Hela-S3	cervix:	n/a	n/a
30	CREB1	chr9:16192168-16192579	H1-hESC	embryonic stem cell:	n/a	n/a
31	CREB1	chr9:16192079-16192555	A549	lung:	n/a	n/a
32	CTCF	chr9:16192022-16192093	GM10266	blood:	n/a	n/a
33	CTCF	chr9:16216980-16217130	AG10803	skin:	n/a	n/a
34	CTCF	chr9:16217140-16217290	HAc	cerebellar:	n/a	n/a
35	CTCF	chr9:16192260-16192410	HVMF	connective:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
36	CTCF	chr9:16192211-16192471	GM10248	blood:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
37	CTCF	chr9:16192280-16192430	HMEC	breast:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
38	CTCF	chr9:16192280-16192430	K562	blood:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
39	CTCF	chr9:16236180-16236330	AG09309	skin:	n/a	chr9:16236230-16236237
40	CTCF	chr9:16192226-16192455	Kidney_OC	kidney:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
41	CTCF	chr9:16236040-16236190	NHDF-neo	bronchial:	n/a	n/a
42	CTCF	chr9:16192085-16192545	H1-hESC	embryonic stem cell:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
43	CTCF	chr9:16192280-16192430	HFF-Myc	foreskin:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
44	CTCF	chr9:16192077-16192563	GM12878	blood:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
45	CTCF	chr9:16192280-16192430	NHEK	skin:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
46	CTCF	chr9:16216880-16217030	HEK293	kidney:	n/a	n/a
47	CTCF	chr9:16191980-16192130	HFF-Myc	foreskin:	n/a	n/a
48	CTCF	chr9:16192199-16192506	MCF-7	breast:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
49	CTCF	chr9:16192180-16192499	A549	lung:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365
50	CTCF	chr9:16192320-16192470	HFF-Myc	foreskin:	n/a	chr9:16192350-16192363 chr9:16192349-16192370 chr9:16192350-16192363 chr9:16192348-16192364 chr9:16192347-16192365

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:16204159-16204209	Hela-S3	cervix:	n/a
2	chr9:16214627-16214677	HAEpiC	amniotic membrane:	n/a
3	chr9:16214627-16214677	SK-N-SH	brain:	n/a
4	chr9:16216112-16216162	HMEC	breast:	n/a
5	chr9:16214627-16214677	HNPCEpiC	eye:	n/a
6	chr9:16214627-16214677	HEEpiC	esophagus:	n/a
7	chr9:16204159-16204209	AG10803	skin:	n/a
8	chr9:16216112-16216162	HIPEpiC	eye:	n/a
9	chr9:16204159-16204209	GM06990	blood:	n/a
10	chr9:16204159-16204209	SKMC	muscle:	n/a
11	chr9:16204159-16204209	LNCaP	prostate:	n/a
12	chr9:16204159-16204209	HCM	heart:	n/a
13	chr9:16216112-16216162	T-47D	breast:	n/a
14	chr9:16214627-16214677	BJ	skin:	n/a
15	chr9:16214627-16214677	HPAEpiC	pulmonary alveolar:	n/a
16	chr9:16216112-16216162	GM12892	blood:	n/a
17	chr9:16214627-16214677	BE2_C	brain:	n/a
18	chr9:16204159-16204209	GM12891	blood:	n/a
19	chr9:16204159-16204209	NT2-D1	testis:	n/a
20	chr9:16204159-16204209	GM12878	blood:	n/a
21	chr9:16204159-16204209	HEEpiC	esophagus:	n/a
22	chr9:16214627-16214677	SAEC	small airway:	n/a
23	chr9:16216112-16216162	HRE	kidney:	n/a
24	chr9:16214627-16214677	HL-60	blood:	n/a
25	chr9:16204159-16204209	H1-hESC	embryonic stem cell:	embryo
26	chr9:16214627-16214677	HRCEpiC	kidney:	n/a
27	chr9:16214627-16214677	PANC-1	pancreas:	n/a
28	chr9:16204159-16204209	ovcar-3	ovarian:	n/a
29	chr9:16204159-16204209	GM19239	blood:	n/a
30	chr9:16216112-16216162	GM12878	blood:	n/a
31	chr9:16204159-16204209	HL-60	blood:	n/a
32	chr9:16204159-16204209	PrEC	prostate:	n/a
33	chr9:16216112-16216162	HCF	heart:	n/a
34	chr9:16204159-16204209	ECC-1	luminal epithelium:	n/a
35	chr9:16216112-16216162	GM19239	blood:	n/a
36	chr9:16214627-16214677	NB4	blood:	n/a
37	chr9:16214627-16214677	CMK	blood:	n/a
38	chr9:16204159-16204209	AoSMC	blood vessel:	n/a
39	chr9:16214627-16214677	AG04450	lung:	fetal
40	chr9:16214627-16214677	MCF10A-Er-Src	breast:	n/a
41	chr9:16216112-16216162	SK-N-MC	brain:	n/a
42	chr9:16214627-16214677	HepG2	liver:	n/a
43	chr9:16216112-16216162	Hela-S3	cervix:	n/a
44	chr9:16204159-16204209	HRE	kidney:	n/a
45	chr9:16216112-16216162	AG04450	lung:	fetal
46	chr9:16214627-16214677	RPTEC	kidney:	n/a
47	chr9:16216112-16216162	HRCEpiC	kidney:	n/a
48	chr9:16214627-16214677	PFSK-1	brain:	n/a
49	chr9:16204159-16204209	CMK	blood:	n/a
50	chr9:16216112-16216162	NB4	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:16191923..16192798-chr9:16648750..16649311,2	MCF-7	breast:
2	chr9:16233531..16235152-chr9:16236701..16238739,2	MCF-7	breast:
3	chr9:16201134..16203881-chr9:16231710..16234448,2	MCF-7	breast:
4	chr9:16207216..16210158-chr9:16217890..16219835,2	MCF-7	breast:
5	chr9:16191835..16192793-chr9:16257298..16257982,2	MCF-7	breast:
6	chr9:16207216..16210158-chr9:16217890..16219835,2	MCF-7	breast:
7	chr9:16191908..16192691-chr9:16266310..16267154,2	MCF-7	breast:
8	chr9:16233531..16235152-chr9:16236701..16238739,2	MCF-7	breast:
9	chr9:16201134..16203881-chr9:16231710..16234448,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf93-7	chr9:16206806-16209226	ucscGeneNc_uc003zmh_1
2	lnc-C9orf92-1	chr9:16203933-16204036	NR_073471
3	lnc-C9orf93-8	chr9:16216806-16219226	NONHSAT130285
4	lnc-C9orf92-1	chr9:16215214-16215277	NR_073471
5	lnc-C9orf92-1	chr9:16215770-16215897	NR_073471

Variant related genes	Relation type
C9orf92	TF binding region
C9orf92	CpG island

Extended variants
information (count: 2781 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:2781 , 50 per page) page: 1 2 3 4 5 6 7 ... 56

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10962321	chr9:16190403-16190404	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs553718306	chr9:16190438-16190439	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs572084012	chr9:16190448-16190449	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs188806250	chr9:16190466-16190467	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs369001849	chr9:16190528-16190529	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs112973160	chr9:16190540-16190541	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs80242354	chr9:16190585-16190586	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs141132597	chr9:16190593-16190594	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs200368758	chr9:16190640-16190641	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs544347313	chr9:16190646-16190647	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs541362154	chr9:16190647-16190648	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs562563436	chr9:16190654-16190655	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs533218359	chr9:16190672-16190673	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs201283232	chr9:16190673-16190674	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs551685148	chr9:16190686-16190687	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs560472839	chr9:16190690-16190691	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs139375672	chr9:16190706-16190707	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs549039903	chr9:16190733-16190734	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs9407717	chr9:16190735-16190736	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs537549188	chr9:16190738-16190739	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs186188182	chr9:16190770-16190771	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs111879106	chr9:16190779-16190780	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs538882325	chr9:16190820-16190821	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs554038902	chr9:16190840-16190841	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs537670218	chr9:16190866-16190867	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs543219180	chr9:16190896-16190897	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs371572616	chr9:16190909-16190910	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs563067095	chr9:16190919-16190920	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs554667236	chr9:16190939-16190940	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs576452658	chr9:16190959-16190960	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs149887647	chr9:16190969-16190970	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs565411151	chr9:16190971-16190972	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs577740486	chr9:16190976-16190977	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs73423619	chr9:16190986-16190987	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs560463633	chr9:16191001-16191002	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs527593644	chr9:16191016-16191017	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs7852665	chr9:16191094-16191095	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs560746314	chr9:16191125-16191126	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs189617887	chr9:16191193-16191194	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs144882622	chr9:16191225-16191226	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs535015614	chr9:16191256-16191257	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs77838205	chr9:16191257-16191258	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs4961665	chr9:16191258-16191259	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs565983574	chr9:16191270-16191271	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs577239732	chr9:16191279-16191280	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs142110287	chr9:16191309-16191310	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs554915211	chr9:16191354-16191355	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs576341993	chr9:16191399-16191400	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs565380508	chr9:16191471-16191472	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs180839617	chr9:16191499-16191500	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	21611746	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16179800-16192000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr9:16185200-16193600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr9:16185600-16192200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
4	chr9:16185600-16196400	Weak transcription	Aorta	Aorta
5	chr9:16187800-16191400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
6	chr9:16189800-16192000	Weak transcription	Primary T cells from cord blood	blood
7	chr9:16190000-16190800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr9:16190000-16191200	Weak transcription	HSMMtube	muscle
9	chr9:16190000-16193000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
10	chr9:16190600-16192000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr9:16190600-16193600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr9:16190600-16193800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr9:16190800-16191400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
14	chr9:16190800-16192000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr9:16190800-16193000	Enhancers	Colon Smooth Muscle	Colon
16	chr9:16190800-16193400	Enhancers	Fetal Stomach	stomach
17	chr9:16190800-16193600	Enhancers	NHDF-Ad	bronchial
18	chr9:16190800-16193800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr9:16190800-16194000	Enhancers	NH-A	brain
20	chr9:16190800-16194400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr9:16191000-16191400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr9:16191000-16191400	Enhancers	A549	lung
23	chr9:16191000-16191600	Enhancers	Osteobl	bone
24	chr9:16191000-16191800	Enhancers	Placenta Amnion	Placenta Amnion
25	chr9:16191000-16193200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr9:16191000-16193600	Enhancers	HSMM	muscle
27	chr9:16191000-16193600	Enhancers	NHLF	lung
28	chr9:16191000-16194200	Enhancers	Fetal Muscle Leg	muscle
29	chr9:16191200-16191400	Enhancers	Muscle Satellite Cultured Cells	--
30	chr9:16191200-16191600	Enhancers	Placenta	Placenta
31	chr9:16191200-16193200	Enhancers	Hela-S3	cervix
32	chr9:16191200-16193400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
33	chr9:16191200-16193400	Enhancers	Rectal Smooth Muscle	rectum
34	chr9:16191200-16193800	Enhancers	HSMMtube	muscle
35	chr9:16191400-16191600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr9:16191400-16191600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr9:16191400-16191600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
38	chr9:16191400-16192000	Enhancers	HUES6 Cell Line	embryonic stem cell
39	chr9:16191400-16192000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr9:16191400-16192000	Enhancers	Stomach Smooth Muscle	stomach
41	chr9:16191400-16192200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr9:16191400-16192200	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr9:16191400-16192200	Bivalent Enhancer	Fetal Heart	heart
44	chr9:16191400-16192400	Enhancers	Breast Myoepithelial Primary Cells	Breast
45	chr9:16191400-16192600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr9:16191400-16192800	Flanking Active TSS	A549	lung
47	chr9:16191400-16193400	Enhancers	Fetal Lung	lung
48	chr9:16191400-16193800	Enhancers	ES-I3 Cell Line	embryonic stem cell
49	chr9:16191600-16192000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
50	chr9:16191600-16192000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links